I looked back, and you are correct as they did put the paragraph you mentioned in the 10 Q (March2015) about the suspension of trials due to insufficient funds

However, look back at their press release in Aug 2013 !!!(see below) pre-clinical 10-12 weeks , followed by clinical trials in december 2013. Then no word or mention until March 2015 !

CardioGenics Announces Commencement of Beta-Site Testing Beta-Site Testing of the Company's QL Care™ Analyzer and Troponin-I Test Begins in Two Hospitals MISSISSAUGA, Ontario - August 21, 2013 - CardioGenics Holdings Inc. (OTCBB:CGNH), developer of the QL Care™ analyzer, an ultra-sensitive immunoassay point-of-care analyzer, and other products targeting the In-Vitro-Diagnostics testing market, announced today that it has commenced beta-site testing of its QL Care™ Analyzer and first cardiovascular test, Troponin-I. The beta-site testing was commenced in two hospitals affiliated with Wayne State University. In accordance with the approved testing protocol, blood samples from approximately 200 patients presenting with chest pain will be analyzed for Troponin I by both the QL Care™ Analyzer and the Siemens ADVIA Centaur XP, a central laboratory-based immunoassay analyzer. The test results of the analyzed samples will be compared in order to document the "equivalence" of both devices. The Company expects beta-site testing to be completed within 10- 12 weeks.